News
BDRX
3.250
+4.84%
0.150
Weekly Report: what happened at BDRX last week (0406-0410)?
Weekly Report · 1d ago
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 5d ago
Why GameSquare Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/07 09:20
Weekly Report: what happened at BDRX last week (0330-0403)?
Weekly Report · 04/06 10:04
Upcoming Stock Splits This Week (April 6-10, 2026) – Stay Invested
TipRanks · 04/05 15:28
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
TipRanks · 04/02 23:50
Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today?
Benzinga · 04/02 17:15
Biodexa Pharmaceuticals Stock Surges 69% Over Partnership With Syngene International
NASDAQ · 04/02 15:33
Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene
TipRanks · 04/02 13:12
Biodexa Pharma Partners With Syngene International To Manufacture Both MTX240 Active Pharmaceutical Ingredient And Dosage Form
Benzinga · 04/02 12:37
Biodexa, Tanner Pharma launch global early access program for FAP patients
TipRanks · 03/31 12:47
Weekly Report: what happened at BDRX last week (0323-0327)?
Weekly Report · 03/30 10:05
Biodexa Pharmaceuticals Posts 2025 Preliminary Results and Deepens GI Cancer-Focused Pipeline
TipRanks · 03/27 21:59
Preliminary Results for the Year Ended 31 December 2025
Barchart · 03/27 16:00
Biodexa Pharmaceuticals management to meet with Maxim
TipRanks · 03/23 14:45
Biodexa Pharma Enters Into Strategic Partnership With Tanner Pharma Group To Make eRapa Available For FAP Patients Via Early Access Program And Named Patient Prescribing
Benzinga · 03/23 12:33
Weekly Report: what happened at BDRX last week (0316-0320)?
Weekly Report · 03/23 10:01
Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
TipRanks · 03/18 22:00
Biodexa Pharmaceuticals announces ADR ratio change
Seeking Alpha · 03/18 21:10
More
Webull provides a variety of real-time BDRX stock news. You can receive the latest news about Biodexa Pharmaceuticals plc through multiple platforms. This information may help you make smarter investment decisions.
About BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.